CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 11th Annual BIO CEO & Investor Conference on Tuesday, February 10, 2009, at 9:30 a.m. ET at The Waldorf-Astoria in New York.
